The growing threat of AMR
The world is losing its most powerful tool in healthcare: antibiotics.
The reason: rapidly rising antibiotic-resistant infections – also called antimicrobial resistance, or AMR.
These infections can affect anyone, of any age, in any country. AMR is a universal issue that impacts us all – we are all at risk.
Antibiotic resistance undermines every aspect of medicine today. We rely on the availability of effective antibiotics to be able to do everything from wisdom tooth extractions to organ transplantation to cancer chemotherapy.
Bridging the gap
The ground-breaking AMR Action Fund expects to invest more than US$1 billion to bridge the funding gap and respond to the AMR threat.
The Fund aims to bring 2-4 new antibiotics to market this decade that will save patient lives.
The concept of the AMR Action Fund has been developed in collaboration with the World Health Organization, the European Investment Bank, and the Wellcome Trust. It aims to overcome key technical and funding barriers of late-stage antibiotic development and will work with governments to ensure there is a sustainable pipeline of new antibiotics to fight superbugs.
Together, we must act now to safeguard our future from this global threat.